AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
INTERFERON BETA-1A in Tunisia
8 products registered with DPM — 0 active, 8 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| REBIF Solution injectable / 44 µg/0.5 ml | 22073034H | MERCK EUROPE B.V | expired | 9 Jun 2021 |
| REBIF Solution injectable / 22 µg/0.5 ml | 22073033H | MERCK EUROPE B.V | expired | 9 Jun 2021 |
| REBIF 22 µG Solution injectable / 6 MUI | 22073031H | MERCK EUROPE B.V | expired | 30 Mar 2021 |
| REBIF Solution injectable / 12 MUI/0.5 ml | 22073032H | MERCK EUROPE B.V | expired | 30 Mar 2021 |
| AVONEX Solution injectable / 30 µg/0.5 ml | 10913013H | BIOGEN Idec Ltd | expired | 10 Aug 2015 |
| REBIF Solution injectable / 22 µg/0.5 ml | 6363054H | MERCK SERONO EUROPE Limited UK | expired | 19 Jan 2011 |
| REBIF Solution injectable / 44 µg/0.5 ml | 6363055H | MERCK SERONO EUROPE Limited UK | expired | 19 Jan 2011 |
| AVONEX Solution injectable / 6 MUI | 10913012H | BIOGEN Idec Ltd | expired | 27 Aug 2007 |
INTERFERON BETA-1A — DPM Registration Details
DPM (Tunisia) has 8 registered products containing INTERFERON BETA-1A, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track INTERFERON BETA-1A registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.